Literature DB >> 23453333

Multidisciplinary management of gastric cancer.

Jamal G Misleh1, Peter Santoro, Jonathon F Strasser, Joseph J Bennett.   

Abstract

Treatment of gastric cancer involves a multidisciplinary approach to achieve long-term outcome, including surgery, chemotherapy, and radiation therapy. Most patients present with advanced disease and are not candidates for a curative approach. Palliative chemotherapy is recommended for symptom control and for short-term advances in survival. Surgery combined with different chemotherapy and chemoradiation options improves survival. Initial studies focused on adjuvant chemoradiation and showed improved survival. More recent trials have demonstrated that perioperative chemotherapy before and after surgery provides a survival advantage. Such an approach may also downstage marginal patients who can then be selected to undergo curative resection and complete adjuvant chemotherapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23453333     DOI: 10.1016/j.soc.2012.12.013

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  5 in total

1.  MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer.

Authors:  Liming Xie; Zhiwei Zhang; Zhiqin Tan; Rongfang He; Xi Zeng; Yuanjie Xie; Suyun Li; Guohua Tang; Hailin Tang; Xiusheng He
Journal:  Mol Cell Biochem       Date:  2014-07       Impact factor: 3.396

2.  Multi-Modality Treatment for Patients With Metastatic Gastric Cancer: A Real-World Study in China.

Authors:  Lin Zhao; Jiarui Li; Chunmei Bai; Yongdu Nie; Guole Lin
Journal:  Front Oncol       Date:  2019-11-01       Impact factor: 6.244

3.  The efficacy and feasibility of adopting intravenous chemotherapy and oral S-1 as a sequential therapy for postoperative gastric cancer patients.

Authors:  Long Yan; Hongbin Liu; Hongtao Li; Xiaopeng Han; Tingbao Cao; Chaoyang Wang; Gaitian Li
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer.

Authors:  Shihua Wu; Feng Liu; Liming Xie; Yaling Peng; Xiaoyuan Lv; Yaping Zhu; Zhiwei Zhang; Xiusheng He
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

5.  Role of platelet infiltration as independent prognostic marker for gastric adenocarcinomas.

Authors:  Jing Wang; Miao Zhang; Ting Zhou; Shengmei Zhao; Zhenguo Su; Xiangdong Liu
Journal:  J Clin Lab Anal       Date:  2020-03-31       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.